Global Dermal Fillers Market Size, Share & Growth | Opportunities and Forecast, 2020-2027
発行: DataM Intelligence
ページ情報: 英文 180 Pages
Global Dermal Fillers Market is segmented By Product Type (Absorbable Dermal Fillers, Non-Absorbable Dermal Fillers), By Material (Hyaluronic Acid (HA), Poly-L-Lactic Acid (PLA), Calcium Hydroxylapatite (CaH), Polymethylmethacrylate (PMMA), Collagen), By Application (Facial Line Correction Treatment, Lip Enhancement, Scar Treatment), By End-user (Hospitals, Ambulatory Surgical Centers, Dermatology Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027
The Global Dermal Fillers Market is expected to grow at a CAGR of 9.6% during the forecasting period (2020-2027).
With aging, facial skin begins to lose its natural flexibility and hydration, which help in the supporting of the face. This results in the sagging of skin and wrinkles on the face. Dermal fillers, used in non-invasive treatments for facial rejuvenation, are anti-aging agents. They can replace lost volume to help smooth wrinkles, plump the lips, and enable the body in generating its own collagen, restoring a more youthful and natural facial appearance. Dermal fillers are applied through tiny facial injections to specific areas of the face or other parts of the body.
The global market for the Dermal Fillers Market is primarily driven by a growing focus on aesthetics which is increasing demand for anti-aging products coupled with growing geriatric population and introduction of improved dermal fillers such as synthetic calcium hydroxylapatite fillers. According to the American Society of Plastic Surgeons report, there was a 50% increase of Lip Filler procedures between 2000-2017, and in 2017, more than 27,000 lip filler procedures were done in the US. Moreover, the rising demand for non-surgical procedures for facial correction, favorable reimbursement and favorable support from regulatory bodies concerning product approvals in new application areas along with the commercialization of innovative solutions in the market further boost the market growth. For instance, in May 2018, the US FDA approved the first ever hyaluronic acid (HA) dermal filler for an area other than the face.
However, the lack of regulations on the usage of dermal filler products, shortage of skilled specialist dermatologists, and growing circulation of counterfeit products in the market may hinder market progress.
By Product Type, the global Dermal Fillers market is bifurcated into Non-Absorbable Dermal Fillers and Absorbable Dermal Fillers. Absorbable Dermal Fillers dominates the market share as Hyaluronic acid, Collagen, Calcium hydroxylapatite, and Poly-L-lactic acid-based dermal fillers all fall under this segment and are favored as a filler.
By Material, the global Dermal Fillers market is segmented into Hyaluronic acid (HA), Collagen, Calcium hydroxylapatite (CaH), and Poly-L-lactic acid (PLLA), Polymethylmethacrylate (PMMA), and others. HA holds the most significant market share and is expected to continue to grow at a steady pace owing to its long-lasting and more natural looking results. Moreover, HA advantages of improves elasticity increases hydration, and have no allergic reaction that are associated with collagen treatment are factors increasing market share. Additionally, continues product launches and FDA approvals further boost the market. For instance, in November 2018, Galderma Laboratories received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft, an HA dermal filler, for cheek augmentation and the correction of age-related midface contour deficiencies.
Among the considered regions, North America is the largest consumer of Dermal Fillers. Key factors driving the growth in the North American Dermal Fillers market is owing to the increasing awareness about aesthetic procedures as individuals in this region are more conscious about appearances and are accepting of advanced treatment methods. According to the American Society for Aesthetic Plastic Surgery (ASAPS), Americans spent more than US$390 million on skin rejuvenation procedures in 2017. A study conducted by Galderma S.A. in 2017 estimated that 2 million women undergo injectable aesthetic procedures in the US. Moreover, the easy availability to the product, the presence of a well-established cosmetic industry and rising demand for non-invasive aesthetic procedures in the region is expected to propel the market further.
The Asia Pacific is expected to be the fastest growing market as the region offers attractive opportunities to international companies with its relatively relaxed regulatory scenario. China is one of the attractive markets for industry players due to the presence of a large target population base. South Korea holds a significant regional market share and is one of the largest contributors to the region's revenue, owing to the great demand for aesthetic procedures and surging incidences of different skin problems. South Korea is considered to be the plastic surgery capital of the world.
Several key players adopt merger and acquisitions policies such as a partnership with associated companies to help them stand out as strong competitors in the market and also expand the sales in the global Dermal Fillers market. New product launches, FDA approvals, and regional expansion are other key strategies take on by the leading players to improve their market presence.
Major Players in the global Dermal Fillers market include Allergan plc, Merz Pharma, Galderma (Nestle Skin Health), and Teoxane Laboratories.
In December 2018, Prollenium US announced the immediate availability of Revanesse Versa +. Revanesse Versa + can be used to boost facial volume or to augment and enhance specific features. The treatment can reduce the appearance of wrinkles, fine lines and hollows that may appear over time.
In November 2018, Galderma Laboratories, L.P., a global leader focused on medical solutions in skin health, received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft, a hyaluronic acid (HA) dermal filler, with a small blunt tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
In October 2018, Allergan plc announced the launch of a new JUVEDERM advertising campaign created to empower the next generation of consumers to JUVEDERM IT. JUVEDERM IT marks the first new advertising campaign in three years for the world's #1 selling dermal filler collection and was designed to further Allergan's goal of making the JUVEDERM Collection of Fillers a first choice and household name for consumers.
In May 2018, Nestle Skin Health, a global leader focused on meeting the world's increasing skin health needs, announced that the U.S. FDA approved the hyaluronic acid (HA) dermal filler Restylane Lyft for the correction of age-related volume loss in the back of the hands. Restylane Lyft is the first and only HA injectable gel to be FDA-approved for restoring fullness to the back of the hands providing more youthful-looking skin. It is also the first-ever HA dermal filler to receive FDA approval for an area other than the face.
In October 2017, Galderma, a global leader focused on medical solutions in skin health, received US FDA approval for the use of a small blunt tip cannula with Restylane Silk for lip augmentation.Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specifically designed for lip augmentation and the smoothing of wrinkles around the mouth in patients 21 years of age and older and is now the first HA dermal filler to be approved for lip injection via cannula.
Scope of the Report
The global market for the Dermal Fillers Market is primarily driven by a growing focus on aesthetics which is increasing demand for anti-aging products coupled with growing geriatric population and introduction of improved dermal fillers.
Absorbable Dermal Fillers dominates the market share as Hyaluronic acid, Collagen, Calcium hydroxylapatite, and Poly-L-lactic acid based dermal fillers all fall under this segment and are favored as a filler. HA holds the most significant market share and is expected to continue to grow at a steady pace owing to its longer lasting and more natural looking results.
Key factors driving the growth in the North American Dermal Fillers market is owing to the increasing awareness about aesthetic procedures as individuals in this region are more conscious about appearances and are accepting of advanced treatment methods.
New product launches and FDA approvals are other ways the leading players improve their market presence. For instance, in May 2018, Nestle Skin Health announced that the U.S. FDA approved the hyaluronic acid (HA) dermal filler Restylane Lyft for the correction of age-related volume loss in the back of the hands.
Visualize the composition of the global Dermal Fillers Market across each indication, in terms of Material and Application options, highlighting the key commercial assets and players.
Identify commercial opportunities in global Dermal Fillers Market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the global Dermal Fillers Market - level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Type mapping in excel for the key Services of all major market players.
Equipment Suppliers/ Buyers
Type Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Mineral Fillers Market
Table of Content